Xencor | XNCR - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
AbbVie USD 7.61B 2.04B 2026-06
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amgen USD 2.08B 570M 2026-03
Arrowhead Research USD -178.9M 41.34M 2026-06
AstraZeneca USD 4.81B 894M 2026-06
Biogen USD 647.3M 269.6M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Cytokinetics USD -206.03M 23M 2026-03
GlaxoSmithKline GBP 2.68B 532M 2026-06
J&J USD 8.66B 839M 2026-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Merck USD -3.53B 6.95B 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Xencor USD -21.92M 106.72M 2026-06